Urticaria exacerbations and adverse reactions in patients with chronic urticaria receiving COVID-19 vaccination: Results of the UCARE COVAC-CU study
Background: Concern about disease exacerbations and fear of reactions after coronavirus disease 2019 (COVID-19) vaccinations are common in chronic urticaria (CU) patients and may lead to vaccine hesitancy. Objective: We assessed the frequency and risk factors of CU exacerbation and adverse reactions...
- Autores:
-
Sánchez Caraballo, Jorge Marío
Giménez Arnau, Ana María
Kocaturk, Emek
Vera Ayala, Carolina E.
Criado, Paulo Ricardo
- Tipo de recurso:
- Article of investigation
- Fecha de publicación:
- 2023
- Institución:
- Universidad de Antioquia
- Repositorio:
- Repositorio UdeA
- Idioma:
- eng
- OAI Identifier:
- oai:bibliotecadigital.udea.edu.co:10495/46816
- Acceso en línea:
- https://hdl.handle.net/10495/46816
- Palabra clave:
- Vacunas contra la COVID-19 - efectos adversos
COVID-19 Vaccines - adverse effects
COVID-19 - prevención y control
COVID-19 - prevention and control
Urticaria Crónica
Chronic Urticaria
Estudios Retrospectivos
Retrospective Studies
Urticaria - tratamiento farmacológico
Urticaria - drug therapy
Vacunación - efectos adversos
Vaccination - adverse effects
Brote de los Síntomas
Symptom Flare Up
Omalizumab
https://id.nlm.nih.gov/mesh/D000086663
https://id.nlm.nih.gov/mesh/D000086382
https://id.nlm.nih.gov/mesh/D000080223
https://id.nlm.nih.gov/mesh/D012189
https://id.nlm.nih.gov/mesh/D014581
https://id.nlm.nih.gov/mesh/D014611
https://id.nlm.nih.gov/mesh/D000067251
https://id.nlm.nih.gov/mesh/D000069444
ODS 3: Salud y bienestar. Garantizar una vida sana y promover el bienestar de todos a todas las edades
- Rights
- openAccess
- License
- http://creativecommons.org/licenses/by-nc-nd/4.0/
